Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 4
2013 1
2014 2
2015 1
2016 1
2017 1
2018 3
2020 1
2021 1
2022 5
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean cools f (191 results)?
Role of IFN-α in Rheumatoid Arthritis.
Lin CMA, Isaacs JD, Cooles FAH. Lin CMA, et al. Among authors: cooles fah. Curr Rheumatol Rep. 2024 Feb;26(2):37-52. doi: 10.1007/s11926-023-01125-6. Epub 2023 Dec 5. Curr Rheumatol Rep. 2024. PMID: 38051494 Free PMC article. Review.
Precision medicine: the precision gap in rheumatic disease.
Lin CMA, Cooles FAH, Isaacs JD. Lin CMA, et al. Among authors: cooles fah. Nat Rev Rheumatol. 2022 Dec;18(12):725-733. doi: 10.1038/s41584-022-00845-w. Epub 2022 Oct 10. Nat Rev Rheumatol. 2022. PMID: 36216923 Review.
Basic Mechanisms of JAK Inhibition.
Lin CM, Cooles FA, Isaacs JD. Lin CM, et al. Among authors: cooles fa. Mediterr J Rheumatol. 2020 Jun 11;31(Suppl 1):100-104. doi: 10.31138/mjr.31.1.100. eCollection 2020 Jun. Mediterr J Rheumatol. 2020. PMID: 32676567 Free PMC article. Review. No abstract available.
Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming.
Cooles FAH, Tarn J, Lendrem DW, Naamane N, Lin CM, Millar B, Maney NJ, Anderson AE, Thalayasingam N, Diboll J, Bondet V, Duffy D, Barnes MR, Smith GR, Ng S, Watson D, Henkin R, Cope AP, Reynard LN, Pratt AG; RA-MAP Consortium; Isaacs JD. Cooles FAH, et al. Ann Rheum Dis. 2022 Aug 11;81(9):1214-1223. doi: 10.1136/annrheumdis-2022-222370. Ann Rheum Dis. 2022. PMID: 35680389 Free PMC article.
Pathophysiology of rheumatoid arthritis.
Cooles FA, Isaacs JD. Cooles FA, et al. Curr Opin Rheumatol. 2011 May;23(3):233-40. doi: 10.1097/BOR.0b013e32834518a3. Curr Opin Rheumatol. 2011. PMID: 21427580 Review.
Emerging immunotherapies for rheumatoid arthritis.
Reynolds G, Cooles FA, Isaacs JD, Hilkens CM. Reynolds G, et al. Among authors: cooles fa. Hum Vaccin Immunother. 2014;10(4):822-37. doi: 10.4161/hv.27910. Epub 2014 Feb 17. Hum Vaccin Immunother. 2014. PMID: 24535556 Free PMC article. Review.
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial.
Cope AP, Jasenecova M, Vasconcelos JC, Filer A, Raza K, Qureshi S, D'Agostino MA, McInnes IB, Isaacs JD, Pratt AG, Fisher BA, Buckley CD, Emery P, Ho P, Buch MH, Ciurtin C, van Schaardenburg D, Huizinga T, Toes R, Georgiou E, Kelly J, Murphy C, Prevost AT; APIPPRA study investigators. Cope AP, et al. Lancet. 2024 Mar 2;403(10429):838-849. doi: 10.1016/S0140-6736(23)02649-1. Epub 2024 Feb 13. Lancet. 2024. PMID: 38364839 Free article. Clinical Trial.
Treg cells in rheumatoid arthritis: an update.
Cooles FA, Isaacs JD, Anderson AE. Cooles FA, et al. Curr Rheumatol Rep. 2013 Sep;15(9):352. doi: 10.1007/s11926-013-0352-0. Curr Rheumatol Rep. 2013. PMID: 23888361 Review.
20 results